ROBERTA STEPHENSON: Open Payments
NPI 1669915427 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,990 in 67 payments from 27 companies in 2025. Trend: 2023 $0 · 2024 $1,572 · 2025 $1,990
Food & beverage: $1,687Education: $303
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $294 |
| Astellas Pharma US Inc | 3 | $216 |
| Genmab U.S., Inc. | 7 | $189 |
| Merck Sharp & Dohme LLC | 8 | $178 |
| Novartis Pharmaceuticals Corporation | 5 | $130 |
| Janssen Biotech, Inc. | 4 | $106 |
| SEAGEN INC. | 1 | $99 |
| Karyopharm Therapeutics Inc. | 3 | $75 |
| Eisai Inc. | 3 | $74 |
| Adaptive Biotechnologies Corporation | 2 | $68 |
Products named: ELAHERE, KEYTRUDA, Tivdak, Epkinly, KISQALI, XPOVIO, Lenvima, clonoSEQ.
Industry payments across TX — which companies pay providers there.
